GB9015888D0 - Vectors - Google Patents

Vectors

Info

Publication number
GB9015888D0
GB9015888D0 GB909015888A GB9015888A GB9015888D0 GB 9015888 D0 GB9015888 D0 GB 9015888D0 GB 909015888 A GB909015888 A GB 909015888A GB 9015888 A GB9015888 A GB 9015888A GB 9015888 D0 GB9015888 D0 GB 9015888D0
Authority
GB
United Kingdom
Prior art keywords
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909015888A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
SmithKline Biological SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA, SmithKline Biological SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB909015888A priority Critical patent/GB9015888D0/en
Publication of GB9015888D0 publication Critical patent/GB9015888D0/en
Priority to PCT/EP1991/001332 priority patent/WO1992001796A1/fr
Priority to AU81012/91A priority patent/AU8101291A/en
Priority to EP91912483A priority patent/EP0544685A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB909015888A 1990-07-19 1990-07-19 Vectors Pending GB9015888D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB909015888A GB9015888D0 (en) 1990-07-19 1990-07-19 Vectors
PCT/EP1991/001332 WO1992001796A1 (fr) 1990-07-19 1991-07-13 Vecteurs
AU81012/91A AU8101291A (en) 1990-07-19 1991-07-13 Mycobacterial expression vector
EP91912483A EP0544685A1 (fr) 1990-07-19 1991-07-13 Vecteurs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015888A GB9015888D0 (en) 1990-07-19 1990-07-19 Vectors

Publications (1)

Publication Number Publication Date
GB9015888D0 true GB9015888D0 (en) 1990-09-05

Family

ID=10679341

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909015888A Pending GB9015888D0 (en) 1990-07-19 1990-07-19 Vectors

Country Status (4)

Country Link
EP (1) EP0544685A1 (fr)
AU (1) AU8101291A (fr)
GB (1) GB9015888D0 (fr)
WO (1) WO1992001796A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566121B1 (en) 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
EP0521220A1 (fr) 1991-06-14 1993-01-07 Institut Pasteur Actinomycétale immunogène recombinant
US6238676B1 (en) 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
US9266930B1 (en) 1993-03-05 2016-02-23 Epimmune Inc. Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
WO1995014713A2 (fr) 1993-11-23 1995-06-01 The Regents Of The University Of California Vaccins a base de produits extracellulaires abondants, leurs procedes de fabrication et leur utilisation
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5843664A (en) * 1996-06-11 1998-12-01 Institut Pasteur Method of selection of allelic exchange mutants
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
FR2767337B1 (fr) * 1997-08-14 2002-07-05 Pasteur Institut Sequences nucleiques de polypeptides exportes de mycobacteri es, vecteurs les comprenant et applications au diagnostic et a la prevention de la tuberculose
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
CA2340330A1 (fr) 1998-08-20 2000-03-02 Aventis Pasteur Limited Molecules d'acide nucleique codant la proteine membrane d'inclusion c de chlamydia
DE60038971D1 (de) 1999-10-22 2008-07-03 Aventis Pasteur Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
EP1792995A3 (fr) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Antigènes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
EP1282702B1 (fr) 2000-05-10 2006-11-29 Sanofi Pasteur Limited Polypeptides immunogeniques codes par des minigenes mage et leurs utilisations
ATE357461T1 (de) 2000-08-25 2007-04-15 Aventis Pasteur Innen-kern oligosaccharide epitopes aus lipopolysacchariden von haemophilus influenza als vakzinen in der prophylaktischen behandlung von haemophilus influenzae infektionen
EP1343894A4 (fr) 2000-11-02 2005-05-04 Univ Singapore Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
EP1864691B1 (fr) 2002-04-09 2011-07-20 Sanofi Pasteur Limited Acide nucléique ACE modifié et vecteurs d'expression
CN106008679A (zh) 2008-12-24 2016-10-12 荷兰王国卫生福利和运动部国家公共卫生和环境研究所 修饰的肺炎链球菌溶血素(ply)多肽
WO2012101509A2 (fr) 2011-01-28 2012-08-02 Sanofi Pasteur Sa Compositions immunologiques contre le vih
JP6193231B2 (ja) 2011-08-08 2017-09-06 チュアラボ オンコロジー, インコーポレーテッドCurelab Oncology, Inc. がんの治療および予防のための、ｐ６２に関する方法および組成物
DK178233B1 (en) 2012-09-17 2015-09-14 Novartis Tiergesundheit Ag Fiskevaccine
EP2914618B1 (fr) 2012-11-02 2017-07-26 Novartis Tiergesundheit AG Flavivirus associés à la maladie de theiler
WO2014140938A2 (fr) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Méthodes immunologiques
CA2935232A1 (fr) 2013-12-29 2015-07-02 Curelab Oncology, Inc. Methodes et compositions relatives a p62/sqstm1 pour traiter et prevenir les maladies associees a une inflammation
DK3177644T3 (da) 2014-08-05 2021-01-11 MabQuest SA Immunologiske reagenser, som binder til PD-1
CN108779168A (zh) 2015-12-05 2018-11-09 沃迪奥斯大学医院中心 Hiv结合剂
WO2017125815A2 (fr) 2016-01-22 2017-07-27 MabQuest SA Réactifs immunologiques
EP3996815A2 (fr) 2019-07-15 2022-05-18 Lausanne University Hospital Agents de liaison au vih
TW202206098A (zh) 2020-08-11 2022-02-16 美商碩騰服務公司 抗冠狀病毒疫苗
CN114315985A (zh) 2020-09-29 2022-04-12 硕腾服务有限责任公司 减毒猪流行性腹泻病毒
WO2023034804A1 (fr) 2021-08-31 2023-03-09 Zoetis Services Llc Alphavirus atténué

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
US5504005A (en) * 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine

Also Published As

Publication number Publication date
EP0544685A1 (fr) 1993-06-09
WO1992001796A1 (fr) 1992-02-06
AU8101291A (en) 1992-02-18

Similar Documents

Publication Publication Date Title
GB9015888D0 (en) Vectors
DE4190756D2 (en) Mikrotom
GB2248044B (en) Improved doll-carriages
GB9006400D0 (en) Bacterial vectors
DE4092449D2 (de) Taschenfederkernmatratze
AU111085S (en) Sunlounger
EP0440493A3 (en) Tape-cartridge case
CS262591A3 (en) Indolonaphthyridines
GB2248607B (en) Improved fishbox
GB9005419D0 (en) Improved depanner
DE4092685D2 (en) Mehrkomponenten-kleb- und -werkstoffverarbeitungssystem
GB9009497D0 (en) Case
AU110900S (en) Facsimilie
GB9015866D0 (en) Vectors
GB9118591D0 (en) Formold limited
GB9009300D0 (en) Vector
CA66527S (en) Case
CA65360S (en) Stomatologic electroanesthetizer
CA66268S (en) Snow-bucket
CA66168S (en) Récipient
CA65836S (en) Attache-case
AU157P (en) SUNFLARE Telopea speciosissima
GB9009537D0 (en) Expression vector
GB9020780D0 (en) Viral vectors
GB9013944D0 (en) Improved airfreshener